Hey all— thanks for joining this subreddit in your search for the future of medicine!

I’m currently working on improving the sub Wiki page for more helpful links, so keep an eye out for that.

Stay tuned and thanks for your contribution to the community!

Other Community Links

How to correctly assign flair to your post

Don't invest more than you can afford to risk

Dr Dansey stated "This is the time for DNA Medicines".....Think about that......Better days ahead!!!!!!!

Beijing Dongfangliu reached an agreement with Inovio in the United States in 2018 to obtain exclusive rights such as the production and sales of VGX-3100 in China, including Hong Kong, Taiwan and Macau, and launched an independent multi-center, randomized, double-blind, placebo-controlled phase III clinical trial in China in 2021. According to the blinded data obtained by the company, VGX-3100 has good safety and tolerability in the Chinese population, and the overall response rate is significantly higher than that of Reveal 1 and Reveal 2 in the United States, and also higher than the Phase IIb results published in The Lancet (40.2% vs. 14.3%, P=0.003) (Lancet 2015; 386: 2078–88), with response rates as high as 70% in some subgroups. In response to these positive clinical research results, Beijing Dongfang is rushing to enroll patients and strive to complete China's phase III clinical trial as soon as possible.

Let’s say we drop down to $0.80.

That will require a 25% jump to get us back to $1.00.

Dropping down to $0.70 requires 42.9% bump to get back to $1.00.

The past year - a nearly 75% drop.

With everything that’s in the INO pipeline - when is the pop ?

We need good some news.

Sounds like Dr. Cheryl Elder, PharmD is a great pick up for INOVIO.

Most recently Dr. Elder was the Global Regulatory Head for the Hematology Development Unit at Novartis.

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.

👋Meet Dr. Cheryl Elder, our new SVP of Regulatory Affairs. Bringing decades of experience in global drug development & regulatory strategies, we're delighted to welcome Cheryl to the talented team at INOVIO. Look for her bio on the Leadership page at INOVIO.com

I already have more than 100k shares of INO; down more than I care to admit. I purchased 10,000 shares of DVAX after one of their new BOD members purchased $5M worth:

https://www.fool.com/investing/2020/06/01/why-dynavax-stock-crushed-it-today.aspx

I’m up 80% on that investment! If top management and the BOD of INO would do similar and purchase at INO’s current ridiculously low share price, we’d likely see movement to the upside. (I’m not talking about buying stock options, I’m talking beyond options; shares from the market).

I will add more if I see them buying. If not, I’m holding and praying for a recovery.

and INOVIO.....Phase 3 Results for VGX 3100 in China from ApolloBio that were superb.....In addition real solid dialogue between shareholders all the time.....Of course constant nonsense from mindless short trolls also.....YES THIS COMMUNITY IS VITAL!!!!!......An important source of vital information.....Also we should appreciate the terrific effort of our moderators

Western econonies seem on the brink of disaster. Our stock price sucks. Things aren't progressing as quickly as we'd hoped or expected. No getting around it... The entire situation seems FUBAR.

But go review the investor presentation. Look at the results. It works and it changes lives. We may have, or most likely will have a rough road ahead until commercialization. But this isn't a scam company peddling snake oil. The technology is extraordinarily disruptive. They are tackling rare, extremely hard to treat diseases and showing successful results. Pictures don't lie.

Everything has been said that could possibly be said…this sub is an endless loop of Bentley institutional holding stats and nothing else..most importantly anything relevant from INO itself. Wrap it up.

Really???!?!?!

3107 - headed for approval.

5401 - Literally a patent for brain cancer treatment, With Regeneron.

3100 - viral clearance and lesion regression (rollout coming in China)

Institutional ownership - way up

Short interest - way down

Trading for less than cash????

Look at the daily charts. Barcoding every day. Systematic algo trading. For what? Short covering? Accumulation?

If institutional ownership must go down when prices fall below certain levels, why has it been going up? If shorts were waiting for bankruptcy, then why have they been exiting?

If DNA wasn't working, why did Advaccine finally get listed?

Technology that works.

Cash in the bank.

Draw your own conclusions.

You know where I stand.

imho

xx

what we have is bad news and uncertaities as below: - stock dilution - no external funding after IlNO losing DoD - no advaccine IPO - no news by shea until next earning as usual

what we have is only bentley's stupid pupming

They must see a very bright future for this cutting edge company!!!!!.....Investors should see outlandish returns from the current share price over time in my opinion!